PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $432,827 | -21.2% | 41,900 | 0.0% | 0.00% | – |
| Q2 2023 | $549,309 | +17.3% | 41,900 | 0.0% | 0.00% | – |
| Q1 2023 | $468,442 | +51.8% | 41,900 | +14.5% | 0.00% | – |
| Q4 2022 | $308,538 | -30.0% | 36,600 | +38.1% | 0.00% | – |
| Q3 2022 | $441,000 | -1.1% | 26,500 | -12.5% | 0.00% | – |
| Q2 2022 | $446,000 | -40.7% | 30,300 | 0.0% | 0.00% | – |
| Q1 2022 | $752,000 | -22.6% | 30,300 | 0.0% | 0.00% | – |
| Q4 2021 | $972,000 | -10.8% | 30,300 | 0.0% | 0.00% | – |
| Q3 2021 | $1,090,000 | -18.5% | 30,300 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $1,337,000 | +151.8% | 30,300 | +161.2% | 0.00% | – |
| Q1 2021 | $531,000 | -16.4% | 11,600 | +26.1% | 0.00% | – |
| Q4 2020 | $635,000 | – | 9,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |